Ilene Fennoy, MD
Overview
Dr. Fennoy is a board certified pediatric endocrinologist with additional certification as a Physician Nutrition Specialist as well as an Obesity Medicine specialist. She received her Doctor of Medicine degree form the University of California, San Francisco and her Masters Degree in Public Health from Columbia University, School of Public Health. Her pediatric training was done in the Department of Social Pediatrics, Montefiore Hospital, Bronx, New York, Nutrition training at the Institute of Human Nutrition, Columbia University and Pediatric Endocrine training with the Pediatric Medicine Branch off the National Institute of Child Health, Bethesda, Maryland.
She has focused much of her research on the comorbidities identified in morbidly obese children and adolescents as well as the impact bariatric surgery has on these problems. In addition, she has been involved in a school based study to evaluate the impact of a nutrition education curriculum and exercise program on the changes in insulin resistance in middle school children.
Areas of Expertise / Conditions Treated
- Disorder of Calcium Metabolism
- Growth Disorder
- Obesity
- Osteoporosis
- Type 2 Diabetes Mellitus
Academic Appointments
- Professor of Pediatrics at CUMC
Administrative Titles
- Medical Director Comprehensive Adolescent Bariatric Surgery Program
- Director, POWER Program for Overweight Education and Reduction
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- HMO
- NYP Employee Plan
- NY Signature
- PPO
- Student Health
Affinity Health Plan
- Medicaid Managed Care
Amerigroup of New Jersey
- New Jersey Services (Medicaid Managed Care)
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
Fidelis Care
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- SelectHealth
WellCare
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- University of California San Francisco School of Medicine
- Internship: Montefiore Medical Center
- Residency: Montefiore Medical Center
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowship: National Institutes of Health
Board Certifications
- Pediatrics
- Pediatric Endocrinology
Research
Childhood obesity represents a serious health threat for children and the next generation of adults involving cardiovascular, diabetes, and fatty liver co-morbidities among others. Current estimates identify 18.5% of all children 2 to 19yr of age with obesity and show limited potential for these children to outgrow this problem. Dr. Fennoy’s research seeks to understand the relationships between the factors that contribute to morbidity in pediatric obesity so that interventions may be targeted to both prevent and treat these conditions. This specifically applies to understanding the role of insulin resistance and its relationship to risk factors for cardiovascular morbidity in the developing child and the interventions and their timing that modulate the development of these comorbidities. Currently her efforts focus on:
1) the child/adolescent presenting with obesity with identification of when and how to intervene to limit progression to morbidity;
2) the adolescent with morbid obesity and the changes they experience in health post bariatric surgery including changes in bone health; and
3) disorders of increased body fat with low bone density such as Klinefelter syndrome.
Research Interests
- Bone health
- Childhood obesity
- Klinefelter syndrome
Clinical Trials
NCT02311894 A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naïve Growth Hormone-Deficient Children (iSTUDY) - This study is ongoing, but not recruiting participants.
For a complete list of publications, please visit PubMed.gov